AstraZeneca plc (AZN) Receives Equal weight Rating from Barclays PLC

AstraZeneca plc (AZN) Receives Equal weight Rating from Barclays PLC


's stock had its "equal weight" rating restated by equities research analysts at Barclays PLC in a research note issued to investors on Tuesday. They presently have a GBX 5,000 target price on the biopharmaceutical company's stock.



from Biotech News